CMS does not publish a single wound care documentation requirement checklist. The requirements come from the Social Security Act’s medical necessity standard, Local Coverage Determinations (LCDs), and the skin substitute/CTP coverage policies, and they are enforced through TPE, RAC, and UPIC review. The practical consequence is that a chart is judged service by service: the E/M, the debridement, the CTP application, and the supply order each have to stand on their own record. This article maps what each of those records must show, offers failing and defensible language side by side, and flags the points where the current text of your own MAC’s policies controls over anything generic.
Where Do CMS Wound Care Documentation Requirements Actually Come From?
Authority runs in layers. The top layer is Social Security Act section 1862(a)(1)(A), which bars payment for services that are not reasonable and necessary for the diagnosis or treatment of illness or injury. Beneath it sit the Medicare Benefit Policy Manual and the Program Integrity Manual, then National Coverage Determinations (NCDs), then the LCDs and billing and coding articles each Medicare Administrative Contractor (MAC) writes for its jurisdiction.
The bottom layer is where most wound care disputes live. Because LCDs differ by jurisdiction, the same chart can pass in one and fail in another, especially for skin substitutes and debridement frequency. A generic checklist cannot tell you which one you are in. Read your own MAC’s LCDs and companion articles in the CMS Medicare Coverage Database, and re-read them when they are revised.
Who reviews the chart
- TPE (Targeted Probe and Educate): run by the MAC. It requests a sample of claims for a specific service, followed by education sessions if you fail a round.
- RAC (Recovery Audit Contractor): reviews claims after payment and pursues overpayments.
- SMRC (Supplemental Medical Review Contractor): performs focused national or regional reviews on topics CMS selects.
- UPIC (Unified Program Integrity Contractor): investigates suspected fraud, waste, and abuse, and can request records in bulk.
Signature rules apply to every record
Chapter 3 of the Medicare Program Integrity Manual (section 3.3.2.4) governs signatures. Reviewers need a legible identifier for the author, either a handwritten or electronic signature. When a signature is missing, a signature attestation statement can cure it in many circumstances, but an attestation is not a substitute for an order or for the clinical content itself, and it will not rescue a note that was written long after the visit. Unsigned, unauthenticated, or late entries are among the easiest reasons for a reviewer to deny a claim. The manual is available at cms.gov.
What Must the Chart Show to Support an E/M Visit in Wound Care?
Office and outpatient E/M levels have followed the 2021 revision: the level is chosen by medical decision making (MDM) or by total time on the date of the encounter. Inpatient and facility-based codes carried similar MDM-or-time logic after the 2023 revisions. Whichever you choose, the note has to show the elements, not assert the level.
In a wound visit, the MDM elements usually look like this:
- Problems: the wound itself plus the conditions that drive it, such as diabetes, venous insufficiency, PAD, or malnutrition, and whether the wound is improving, stalled, or worsening.
- Data: reviewed labs (A1c, albumin), imaging, vascular studies, culture results, and notes from other clinicians, each identified as reviewed.
- Risk: the treatment decision made, such as ordering an advanced therapy, escalating for suspected osteomyelitis, or changing antibiotics, and the prescription drug management or other risk it carried.
Modifier 25 on procedure days
When you debride and also bill an E/M the same day, the E/M must be significant and separately identifiable from the pre-procedure work that is already part of the debridement. The record needs evidence of a distinct evaluation: a problem addressed beyond the wound being debrided, or a decision that goes beyond whether and how to debride. A note that describes only the wound and the procedure does not support a second service.
Weak versus defensible
Compare two versions of the same visit. The weak note reads: “Wound improving, continue plan.” A defensible note records that the diabetic patient’s plantar wound is unchanged in area over two visits, that pedal pulses are diminished and an ABI was ordered, that there is no erythema or purulence to suggest infection, that glycemic control was reviewed against the latest A1c, and that offloading was changed to a total contact cast. The second note shows problem, data, and risk, and it records a decision a reviewer can follow.
Facility-based visits
In facility settings, document whether the visit is an initial or subsequent encounter, who performed the work, and when. If a practitioner and a nurse or other clinician both contribute, the record must make the billing practitioner’s own work identifiable, and the note must be authenticated by that practitioner.
What Documentation Supports Debridement Billing?
Debridement coding is driven by depth and, for many codes, by surface area. “Sharp debridement performed” supports neither. The note should state the deepest tissue removed (subcutaneous tissue, muscle or fascia, or bone), the instrument used (curette, scissors, scalpel, rongeur), and the technique.
Measurements are the second pillar. Codes in the 11042 to 11047 family are tied to the surface area debrided, and 97597 and 97598 are tied to the area of selective debridement. As of October 2026, confirm the current CPT descriptors and thresholds in your coding reference, because the area cutoffs and the add-on structure determine which code, and how many units, the record can support. Record length, width, and depth before debridement, and the size and status of the wound afterward. A pre-procedure measurement alone leaves the reviewer unable to confirm the area actually treated.
Necessity elements
The note should explain why removal was needed, not just that it occurred:
- Describe the tissue: devitalized tissue, adherent slough, eschar, or biofilm, with the percentage of the wound bed involved.
- State the indication, such as impaired granulation, infection risk, or a need to prepare the bed for further therapy.
- Record anesthesia (topical, local, none), bleeding and hemostasis, and how the patient tolerated the procedure.
The denial patterns
Reviewers see the same failures repeatedly. Identical templated language appears across visits, down to the same percentages of slough, which signals cloned documentation and undermines the credibility of every entry. Selective and nonselective codes get mismatched: a note describing instrument-based removal of specific tissue is billed as nonselective, or the reverse. Check your MAC’s LCD wording on frequency and on what it considers medically necessary for repeat debridement, since some policies expect evidence that the wound is responding or that new devitalized tissue is present at each visit.
What Does CMS Expect in CTP and Skin Substitute Documentation?
Cellular and tissue-based product (CTP) documentation is where policy has been moving fastest, so treat the following as a framework and confirm every threshold against the current LCD for your jurisdiction as of October 2026.
Coverage prerequisites
Start by confirming whether your MAC has a skin substitute LCD at all. The new DFU/VLU skin substitute LCDs that were scheduled to take effect January 1, 2026 were withdrawn on December 24, 2025, so only Novitas, CGS, and First Coast currently have active skin substitute LCDs; elsewhere, claims are judged against the general reasonable-and-necessary standard. Where an LCD applies, it generally requires a covered wound type, most often a DFU or VLU, and documented failure of standard of care over a stated period, commonly at least four weeks, so verify the current text. The chart should show what standard of care was actually delivered: offloading for DFUs or compression for VLUs, debridement, infection control, and moisture management. It should also show glycemic control and a vascular assessment adequate for the wound location. A statement that conservative care “failed” without the measurements, dates, and interventions behind it will not carry the claim.
Per-application records
Every application needs its own record: product name, size applied, size wasted, lot or serial number, and application site. Since January 1, 2026, Medicare pays only for the portion of a non-BLA skin substitute actually applied, so the record must support the billed square centimeters exactly. The JW and JZ modifiers no longer apply to these products, and MACs reject claims that carry them; they remain in use only for the few skin substitutes still paid as biologicals. Recording wastage still matters, because it shows the product size chosen was appropriate to the wound.
Size trend and the stop rule
Each visit should record measurements that let a reviewer see the trend. Policies commonly expect measurable progress, and continued applications without a documented reduction in size invite denial. The note should state the decision to continue or discontinue and the clinical reason, and should address the limit on the number of applications per wound if your LCD sets one. For context, Intellicure Analytics tracks the real-world average number of CTP applications per wound by product.
How Has Skin Substitute Payment Changed in 2026?
Under the CY2026 Physician Fee Schedule and OPPS final rules, most skin substitutes (those not licensed as biologics under a BLA) have been paid as incident-to supplies since January 1, 2026, at a single national rate of about $127.14 per square centimeter, geographically adjusted. CMS groups products into three FDA regulatory categories but pays all three the same rate for 2026, while BLA-licensed products stay on ASP-based payment. Court challenges to the rule have so far been dismissed. Because payment now follows the square centimeters applied, the application record is effectively the payment record, even where coverage criteria remain tied to the LCDs. Confirm details against the final rules on cms.gov.
What Orders and Records Support Wound Care Supplies and DME?
Supply and DME claims fail on the order as often as on the visit note. A standard written order needs the beneficiary’s name, the item, the order date, the quantity where required, the prescriber’s name or NPI, and the prescriber’s signature or authentication. Some items fall under the DMEPOS rules for a face-to-face encounter and a written order prior to delivery. Which items require them is set by CMS and updated periodically, so check the current required-list before assuming a dressing or device is exempt.
The order must also tie to the wound you documented. Dressing type, size, change frequency, and quantity should match the assessment: a note describing a 2 cm wound with minimal exudate does not support a monthly quantity sized for a large, heavily draining one. A mismatch between the visit note and the supplier’s order is a common audit finding, and it usually arises because the two are produced in separate systems by different people.
A chart-to-order workflow reduces that gap. When the dressing selection, size, and frequency are entered once in the structured wound assessment and flow into the supply order, the supplier’s paperwork is built from the same data the reviewer will read. Intellicure’s automated medical supply ordering is designed around that principle, moving the order from the chart to the patient’s door without retyping. It reduces transcription mismatches; it does not replace the prescriber’s judgment or signature.
Check the payment setting first
For patients in a Medicare Part A SNF stay, supplies are generally bundled into the facility’s payment, so a separate supplier claim can be denied or create a billing conflict. Confirm the patient’s payment setting before ordering.
How Can a Practice Audit-Proof its Wound Care Documentation?
Audit readiness is a routine, not a project. Pull a sample of charts per provider each month and score them against a fixed checklist:
- Measurements recorded (length, width, depth) at every visit.
- Deepest tissue removed, instrument, and technique stated for debridement.
- Necessity and treatment rationale present and specific to the visit.
- Signature and date present and legible.
- Supply and CTP orders match the note, including quantity, frequency, and wastage.
Template design determines how many of those items the record satisfies without effort. Structured fields that require measurements, tissue type, and treatment rationale prevent the blank and the generic. Free-text defaults that carry forward from the last visit produce the cloned notes reviewers flag. Intellicure’s wound care EHR and mobile app support point-of-care structured charting, so measurements and depth are captured at the bedside rather than reconstructed from memory between stops.
Have a TPE response plan
Decide in advance who receives the additional documentation request (ADR), who assembles the records, and who signs off. Confirm the response deadline stated in the request itself, since the window is set by the contractor’s letter; many practices work from a 45-day period but should verify. Assemble the full record for each claim, including orders, signature attestations where needed, and the relevant LCD language. If a round fails, use the education session to learn exactly which element the reviewer found missing, then correct the template rather than only the individual notes. If you appeal, the same complete record is your case; providers often win appeals once a reviewer reads the full clinical story.
Link documentation to quality reporting
MIPS wound-related measures draw on many of the same data elements: wound measurements, healing status, vascular and nutritional assessment, and offloading or compression. Verify the current 2026 measure set before you map fields to it, but capturing these elements once, in structured form, serves both audit defense and reporting.
Build the Record at the Point of Care, Then Test It Against Your MAC
Defensible wound care documentation is built during the visit from structured measurements, stated depth, specific necessity, and signed orders that match the note. Retrospective cleanup rarely repairs what was never captured. This month, pull a sample of your own charts for each provider and read them against your MAC’s current LCDs and billing articles, as a TPE reviewer would. If the gaps trace back to templates and disconnected ordering, request an Intellicure workflow demo to see how structured charting and supply ordering work together.
